ABOUT THE PROJECT
Pancreatic cancer is currently the fourth cancer mortality cause in the European Union. Pancreatic Ductal Adenocarcinoma (PDAC), the most common pancreatic neoplasm, is particularly aggressive and fast growing. Only about 15 % of patients are diagnosed when tumours are surgically resectable, although poor survival is reported.
We have generated a collection of pancreatic orthotopic PDX mouse models histologically and genetically characterized that represent the majority of human PDAC subtypes. They can be useful to test new therapeutic strategies.
If you have any doubts or concerns about this research team, contact us by filling this form